semaglutide compounding fda enforcement today Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling Out of Shortage, Into Controversy:

Recommended sites include the abdomen, thigh, or upper arm

D.WangY.LiuT.LeeF

Alabdali A, Bacha AB, Alonazi M, Al-Ayadhi L, Alanazi AS, El-Ansary A (2025) Comparative Evaluation of Certain Biomarkers Emphasizing Abnormal GABA Inhibitory Effect and Glutamate Excitotoxicity in Autism Spectrum Disorders

It is administered intravenously in a controlled healthcare setting to ensure safe and accurate dosing

Importantly, the review also notes that individual responses to incretin-based therapies can vary substantially, and weight regain commonly occurs if treatment is discontinued, highlighting the chronic nature of obesity management